Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-07

Clinical Trial Update: Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the potential drug interaction between CKD-519 and rosuvastatin in healthy male subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CKD-519
  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dyslipidemias | Phase 1 | Status: COMPLETED